Finding 1090752 (2023-001)

Material Weakness
Requirement
L
Questioned Costs
-
Year
2023
Accepted
2024-12-14
Audit: 332569

AI Summary

  • Core Issue: There is a material weakness in internal control over financial reporting due to delays in the financial closing process.
  • Impacted Requirements: Timely financial statements must be produced without material misstatements, which was not met.
  • Recommended Follow-Up: Implement changes to finalize the working trial balance and financial statements within four to six months post year-end.

Finding Text

2023-001 Material Weakness in Internal Control over Financial Reporting Condition: The financial closing process for the year ended December 31, 2023 extended through November 2024. During this extended period, there were multiple adjusting entries made to the initial working trial balance, reflecting both late client adjustments and certain errors noted during the audit. These adjusting entries included changes that impacted amounts reported for grants receivable, other current assets, accounts payable, deferred revenues, and the related revenues and expenses. Criteria: Amputee Coalition is required to produce timely financial statements that are free of material misstatements. Cause: Amputee Coalition has experienced significant turnover in its accounting and senior management staff over the last several years. Effect: Amputee Coalition’s late completion of the closing process and financial statements resulted in preliminary financial statements that required significant late adjustments. Recommendation: Amputee Coalition should identify and implement changes in the financial accounting and reporting process to ensure the working trial balance and financial statements are complete and finalized in a more timely manner, at a minimum within four to six months of year end. Management Response: See Section V Corrective Action Plan

Categories

Material Weakness Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 514304 2023-002
    Material Weakness
  • 514305 2023-002
    Material Weakness
  • 514306 2023-002
    Material Weakness
  • 514307 2023-002
    Material Weakness
  • 514308 2023-001
    Material Weakness
  • 514309 2023-001
    Material Weakness
  • 514310 2023-001
    Material Weakness
  • 514311 2023-001
    Material Weakness
  • 1090746 2023-002
    Material Weakness
  • 1090747 2023-002
    Material Weakness
  • 1090748 2023-002
    Material Weakness
  • 1090749 2023-002
    Material Weakness
  • 1090750 2023-001
    Material Weakness
  • 1090751 2023-001
    Material Weakness
  • 1090753 2023-001
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.325 Paralysis Resource Center $4.16M